Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» 23andMe
23andMe
4 takeaways from 23&Me’s planned SPAC deal
MedCity News
Mon, 02/8/21 - 10:37 am
diagnostics
23andMe
SPAC
23andMe to go public via Richard Branson’s SPAC
Stat
Thu, 02/4/21 - 10:40 am
23andMe
Richard Branson
SPAC
genetic testing
Early research from 23andMe strengthens link between blood types and Covid-19
Stat
Tue, 09/15/20 - 10:48 am
23andMe
blood types
COVID-19
genes
23andMe Is Trying to Crack the Genetic Code Behind the Coronavirus
Motley Fool
Tue, 05/19/20 - 10:32 am
23andMe
diagnostics
genomics
COVID-19
coronavirus
23andMe Lays Off 14% Of Workforce Amid Declining DNA Test Sales
Forbes
Thu, 01/23/20 - 11:48 pm
23andMe
layoffs
diagnostics
GSK bets on tech to help boost lagging R&D as it looks to start 23andMe trial
Fierce Biotech
Wed, 01/22/20 - 11:10 am
GSK
23andMe
R&D
Emma Walmsley
23andMe’s First Drug Candidate Licensed to Spanish Pharma Company
Xtalks
Tue, 01/14/20 - 11:26 pm
23andMe
diagnostics
Almirall
Ancestry launches consumer genetics tests for health, intensifying rivalry with 23andMe
Stat
Tue, 10/15/19 - 09:54 am
diagnostics
Ancestry
23andMe
DNA testing
home genetic testing
23andMe and GSK are mining customers’ DNA data in a hunt for new drugs
Marketwatch
Tue, 07/23/19 - 12:09 pm
23andMe
GSK
data
data mining
DNA
DNA testing
drug development
ethics
23andMe is moving into Apple’s territory with a pilot to pull in medical data, not just DNA
CNBC
Sun, 07/14/19 - 04:15 pm
23andMe
diagnostics
Apple
patients
medical data
4 Things Exact Sciences Investors Should Know About 23andMe's New Cancer Test
Motley Fool
Tue, 01/29/19 - 12:01 pm
23andMe
EXACT Sciences
diagnostics
colorectal cancer
Cologuard
23andMe Receives FDA Approval for Inherited Colorectal Cancer Risk Report
Xtalks
Mon, 01/28/19 - 10:02 am
23andMe
colorectal cancer
FDA
genomics
Four Healthcare Startups Raised Over $130 Million Last Month
Forbes
Tue, 08/7/18 - 11:46 pm
startups
23andMe
Gossamer Bio
Alector
Compass Therapeutics
[video+transcript]GlaxoSmithKline Makes a Big Bet on DNA
Motley Fool
Thu, 08/2/18 - 11:13 pm
GSK
23andMe
DNA sequencing
GSK bets $300 million on genetics as CEO plays down break-up talk
Yahoo/Reuters
Wed, 07/25/18 - 09:25 am
GSK
23andMe
Emma Walmsley
How 23andMe Quelled FDA Concerns About DTC Breast Cancer Gene Test
Forbes
Sat, 03/24/18 - 09:04 am
23andMe
FDA
diagnostics
breast cancer
FDA approves first direct-to-consumer test for breast cancer risk
Stat
Tue, 03/6/18 - 02:18 pm
FDA
diagnostics
DTC
breast cancer
23andMe
BRCA
23andMe Raises $250M For Consumer Disease-Risk Tests, Drug R&D
Xconomy
Tue, 09/12/17 - 09:44 pm
23andMe
R&D
diagnostics
23andMe, Lundbeck unveil mega investigation of genetics' role in depression
BioPharma Dive
Thu, 08/3/17 - 10:58 am
23andMe
Lundbeck
genetics
bipolar disorder
major depressive disorder
23andMe is back: FDA allows marketing of genetic health risk tests
Mass Device
Sat, 04/22/17 - 01:10 pm
FDA
23andMe
diagnostics
Pages
« first
‹ previous
1
2
3
next ›
last »